Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 
Howard  Katzenstein

Howard Katzenstein, M.D.

Professor of Pediatrics
Scott and Tracie Hamilton Chair in Cancer Survivorship
Medical Director, Pediatric Hematology Oncology

  • Appointments
    615-936-1762
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Monroe Carell Jr. Children's Hospital at Vanderbilt
    615-936-1000

    Office
    615-936-1762
  • Faxes
    Office Fax
    615-936-1767
    Clinic Fax
    615-936-1767
  • Addresses
    Clinic
    Monroe Carell Jr Children's Hospital at Vanderbilt
    One Children's Way
    6th floor, Doctors Office Tower
    Nashville, TN 37232

    Monroe Carell Jr. Children's Hospital at Vanderbilt
    2200 Children's Way
    Nashville, TN 37232
    Website

    Office
    #396c PRB
    2220 Pierce Avenue, #396c PRB
    Nashville, TN 37232
Profile

Children with cancer and blood disorders are candidates for novel therapeutic strategies to cure patients with refractory and/or recurrent disease. Current approaches using traditional chemotherapy have largely reached their limit and the focus must now be on innovative alternative biologic strategies as well as novel agents.
Read more ....

Children with cancer and blood disorders are candidates for novel therapeutic strategies to cure patients with refractory and/or recurrent disease. Current approaches using traditional chemotherapy have largely reached their limit and the focus must now be on innovative alternative biologic strategies as well as novel agents. My career has been focused on translational and clinical research that can impact our patients. 

 

One of my primary areas of interest during my career has been exploring new treatments for pediatric solid tumors. My laboratory efforts were initially focused on identifying novel potential therapeutic targets and approaches for neuroblastoma. Concurrently, I was involved in the development of novel treatment designs for clinical trials.  

 

My personal experience is in the design and conduct of two successful national trials for the treatment of patients with hepatoblastoma P9645 and AHEP0731 within the Children’s Oncology Group. I have also been involved with COG clinical studies for patients with intermediate risk neuroblastoma (ANBL0531) and primary relapsed neuroblastoma (ANBL1221) and have also designed several investigator initiated early phase trials that are currently accruing patients. In addition, for a decade I have provided institutional leadership and oversight of clinical research activities. These experiences provide me with the ability to successfully design, conduct and oversee all phases of early phase pediatric cancer clinical trials. 

Education
University of Illinois, BS, magna cum laude, 1987 University of Illinois, MD, with honors, 1991 Children's Hospital of Pittsburgh, pediatric residency, 1994 Children's Memorial Hospital, pediatric hematology/oncology fellowship, 1997